Cargando…
Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma
Minimally‐invasive tools to assess tumour presence and burden may improve clinical management. FDG‐PET (metabolic) imaging is the current gold standard for interim response assessment in patients with classical Hodgkin Lymphoma (cHL), but this technique cannot be repeated frequently. Here we show th...
Autores principales: | Drees, Esther E. E., Roemer, Margaretha G. M., Groenewegen, Nils J., Perez‐Boza, Jennifer, van Eijndhoven, Monique A. J., Prins, Leah I., Verkuijlen, Sandra A. W. M., Tran, Xuan‐Mai, Driessen, Julia, Zwezerijnen, G. J. C., Stathi, Phylicia, Mol, Kevin, Karregat, Joey J. J. P., Kalantidou, Aikaterini, Vallés‐Martí, Andrea, Molenaar, T. J., Aparicio‐Puerta, Ernesto, van Dijk, Erik, Ylstra, Bauke, Groothuis‐Oudshoorn, Catharina G. M., Hackenberg, Michael, de Jong, Daphne, Zijlstra, Josée M., Pegtel, D. Michiel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282992/ https://www.ncbi.nlm.nih.gov/pubmed/34295456 http://dx.doi.org/10.1002/jev2.12121 |
Ejemplares similares
-
Blood-based Monitoring of Relapsed/Refractory Hodgkin Lymphoma Patients Predict Responses to Anti-PD-1 Treatment
por: Drees, Esther E. E., et al.
Publicado: (2022) -
Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022) -
Multi-scale spatial modeling of immune cell distributions enables survival prediction in primary central nervous system lymphoma
por: Roemer, Margaretha G.M., et al.
Publicado: (2023) -
Engineering large-scale chromosomal deletions by CRISPR-Cas9
por: Eleveld, Thomas F, et al.
Publicado: (2021) -
The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice
por: Mendeville, Matias, et al.
Publicado: (2022)